News | September 08, 2023
Fermenta Biotech inaugurates customized premix manufacturing plant in Kullu, Himachal Pradesh
The company will develop and produce premixes for human nutrition applications
The company will develop and produce premixes for human nutrition applications
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
The companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics
Dr Jitendra Singh launches API Chapter of AFMC, Pune; inaugurates the first annual conference of API-AFMS Continuing Medical Education (CME) on “Emerging trends in the practice of Medicine”
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older
The approval bolsters the company's Mycophenolate Mofetil portfolio
Subscribe To Our Newsletter & Stay Updated
